(6)Neurology & Neurotherapeutics - MS Clinic Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: (6)Neurology & Neurotherapeutics – MS Clinic

Poster-Disease-modifying Therapy

October 25, 2021

Olikos Study Design: Exploring Maintained Ofatumumab Efficacy in Relapsing MS Patients Who Transition from Intravenous Anti-CD20 Therapy

Background: B-cell depletion in patients with relapsing multiple sclerosis (RMS) using anti-CD20 monoclonal antibodies (mAbs) reduces...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC